GB9504265D0
(en)
*
|
1995-03-03 |
1995-04-19 |
Medeva Plc |
Corticosteroid-containing pharmaceutical composition
|
AUPN814496A0
(en)
*
|
1996-02-19 |
1996-03-14 |
Monash University |
Dermal penetration enhancer
|
AUPO983897A0
(en)
|
1997-10-17 |
1997-11-06 |
Soltec Research Pty Ltd |
Topical antifungal composition
|
AUPP310798A0
(en)
*
|
1998-04-22 |
1998-05-14 |
Soltec Research Pty Ltd |
Vehicle system for a composition comprising a piperidinopyrimidine derivative
|
MXPA01001752A
(es)
|
1998-08-20 |
2002-04-08 |
3M Innovative Properties Co |
Parche en aerosol y sistema de aplicacion de medicamento.
|
US6962691B1
(en)
|
1999-05-20 |
2005-11-08 |
U & I Pharmaceuticals Ltd. |
Topical spray compositions
|
US6228354B1
(en)
*
|
1999-07-02 |
2001-05-08 |
Allegiance Corporation |
Water resistant film-forming antimicrobial skin-preparation
|
US6528086B2
(en)
*
|
1999-09-28 |
2003-03-04 |
Zars, Inc. |
Methods and apparatus for drug delivery involving phase changing formulations
|
US20030044432A1
(en)
*
|
2000-09-29 |
2003-03-06 |
Manetta Vincent E. |
Acne treating composition
|
DE60130917T2
(de)
*
|
2000-12-21 |
2008-07-17 |
Alrise Biosystems Gmbh |
Induziertes phasenübergangsverfahren zur herstellung von hydrophile wirkstoffe enthaltenden mikropartikeln
|
US6528076B2
(en)
|
2001-07-06 |
2003-03-04 |
Magic Herb Corp. |
Topical compositions and methods for treating pain
|
US8501202B2
(en)
*
|
2001-07-09 |
2013-08-06 |
Aqua Pharmaceuticals, Llc |
Sulfacetamide formulations for treatment of skin dermatoses
|
US20040018237A1
(en)
|
2002-05-31 |
2004-01-29 |
Perricone Nicholas V. |
Topical drug delivery using phosphatidylcholine
|
US8435942B2
(en)
*
|
2002-05-31 |
2013-05-07 |
Transdermal Biotechnology, Inc. |
Methods for formulating stabilized insulin compositions
|
EA009024B1
(ru)
*
|
2002-06-25 |
2007-10-26 |
АКРУКС ДиДиЭс ПиТиУай ЭлТиДи |
Фармацевтическая композиция для чрескожной доставки активного агента (варианты)
|
KR20050059000A
(ko)
*
|
2002-06-25 |
2005-06-17 |
코즈메스틱 솔루션즈 프로퍼티 리미티드 |
국소 화장품용 조성물
|
US20050186141A1
(en)
*
|
2002-06-25 |
2005-08-25 |
Acrux Dds Pty Ltd. |
Transdermal aerosol compositions
|
AU2002950506A0
(en)
*
|
2002-07-31 |
2002-09-12 |
Soltec Research Pty Ltd |
Percutaneous delivery system
|
IL152486A0
(en)
|
2002-10-25 |
2003-05-29 |
Meir Eini |
Alcohol-free cosmetic and pharmaceutical foam carrier
|
US9265725B2
(en)
|
2002-10-25 |
2016-02-23 |
Foamix Pharmaceuticals Ltd. |
Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
|
US20080138296A1
(en)
|
2002-10-25 |
2008-06-12 |
Foamix Ltd. |
Foam prepared from nanoemulsions and uses
|
US7704518B2
(en)
|
2003-08-04 |
2010-04-27 |
Foamix, Ltd. |
Foamable vehicle and pharmaceutical compositions thereof
|
US7820145B2
(en)
|
2003-08-04 |
2010-10-26 |
Foamix Ltd. |
Oleaginous pharmaceutical and cosmetic foam
|
US10117812B2
(en)
|
2002-10-25 |
2018-11-06 |
Foamix Pharmaceuticals Ltd. |
Foamable composition combining a polar solvent and a hydrophobic carrier
|
US7700076B2
(en)
|
2002-10-25 |
2010-04-20 |
Foamix, Ltd. |
Penetrating pharmaceutical foam
|
US9211259B2
(en)
|
2002-11-29 |
2015-12-15 |
Foamix Pharmaceuticals Ltd. |
Antibiotic kit and composition and uses thereof
|
ES2532906T5
(es)
|
2002-10-25 |
2022-03-23 |
Foamix Pharmaceuticals Ltd |
Espuma cosmética y farmacéutica
|
US8900554B2
(en)
|
2002-10-25 |
2014-12-02 |
Foamix Pharmaceuticals Ltd. |
Foamable composition and uses thereof
|
US9668972B2
(en)
|
2002-10-25 |
2017-06-06 |
Foamix Pharmaceuticals Ltd. |
Nonsteroidal immunomodulating kit and composition and uses thereof
|
US7141237B2
(en)
|
2003-01-24 |
2006-11-28 |
Connetics Australia Pty Ltd. |
Pharmaceutical foam
|
US7871818B2
(en)
*
|
2003-01-31 |
2011-01-18 |
Roche Madison Inc. |
Membrane active polymers
|
US7186416B2
(en)
|
2003-05-28 |
2007-03-06 |
Stiefel Laboratories, Inc. |
Foamable pharmaceutical compositions and methods for treating a disorder
|
EP1498133A1
(fr)
|
2003-07-18 |
2005-01-19 |
Aventis Pharma Deutschland GmbH |
Utilisation d'inhibiteur de pak pour le traitement d'une maladie articulaire
|
US8795693B2
(en)
|
2003-08-04 |
2014-08-05 |
Foamix Ltd. |
Compositions with modulating agents
|
EP1531333A1
(fr)
|
2003-11-12 |
2005-05-18 |
Aventis Pharma Deutschland GmbH |
Méthode pour la identification d' une risque des troubles thrombogénique par détermination du polymorphisme TAFI-ILE347
|
DE102004019916A1
(de)
*
|
2004-04-21 |
2005-11-17 |
Grünenthal GmbH |
Gegen Missbrauch gesichertes wirkstoffhaltiges Pflaster
|
ES2442386T3
(es)
|
2004-04-23 |
2014-02-11 |
Bundesrepublik Deutschland Letztvertreten Durch Das Robert Koch-Institut Vertreten Durch Seinen Pr |
Método para el tratamiento de condiciones mediadas por células T por la disminución de las células positivas de ICOS in vivo.
|
US20070196323A1
(en)
*
|
2004-06-07 |
2007-08-23 |
Jie Zhang |
Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs
|
US20080019927A1
(en)
*
|
2004-06-07 |
2008-01-24 |
Jie Zhang |
Compositions and methods for dermally treating neuropathy with minoxidil
|
US8907153B2
(en)
|
2004-06-07 |
2014-12-09 |
Nuvo Research Inc. |
Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
|
US20070196457A1
(en)
*
|
2004-06-07 |
2007-08-23 |
Jie Zhang |
Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
|
US8741333B2
(en)
|
2004-06-07 |
2014-06-03 |
Nuvo Research Inc. |
Compositions and methods for treating dermatitis or psoriasis
|
US20070196325A1
(en)
*
|
2004-06-07 |
2007-08-23 |
Jie Zhang |
Compositions and methods for dermally treating infections
|
US20070196453A1
(en)
*
|
2004-06-07 |
2007-08-23 |
Jie Zhang |
Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
|
US20070190124A1
(en)
*
|
2004-06-07 |
2007-08-16 |
Jie Zhang |
Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
|
US8741332B2
(en)
*
|
2004-06-07 |
2014-06-03 |
Nuvo Research Inc. |
Compositions and methods for dermally treating neuropathic pain
|
US20070196293A1
(en)
*
|
2004-06-07 |
2007-08-23 |
Jie Zhang |
Compositions and methods for treating photo damaged skin
|
US20070189978A1
(en)
*
|
2004-06-07 |
2007-08-16 |
Jie Zhang |
Compositions and methods for dermally treating musculoskeletal pain
|
US20070196452A1
(en)
*
|
2004-06-07 |
2007-08-23 |
Jie Zhang |
Flux-enabling compositions and methods for dermal delivery of drugs
|
US20080132580A1
(en)
*
|
2004-12-17 |
2008-06-05 |
Mandavilli Sarveswara Rao Srir |
Dispersion For Delivering Active Agents
|
MX2007010835A
(es)
|
2005-03-11 |
2007-11-09 |
Sanofi Aventis |
Uso de mgc4504.
|
CN102091079B
(zh)
*
|
2005-06-03 |
2014-03-12 |
艾克若克斯Dds有限公司 |
用于透皮给药的方法和组合物
|
AU2006254742C1
(en)
*
|
2005-06-03 |
2011-11-03 |
Acrux Dds Pty Ltd |
Method and composition for transdermal drug delivery
|
US8053000B2
(en)
|
2005-06-07 |
2011-11-08 |
Dr. Reddy's Laboratories Limited |
Compositions for drug delivery
|
US20090214443A1
(en)
*
|
2005-07-28 |
2009-08-27 |
Thomas Chan |
Method for retarding systemic delivery rate for easily absorbable active agents
|
CN101262848B
(zh)
*
|
2005-09-29 |
2011-05-11 |
诺瓦提斯公司 |
抗真菌组合物
|
BRPI0616765A2
(pt)
|
2005-09-29 |
2011-06-28 |
Novartis Ag |
composição antifúngica tópica adaptada para tratar uma infecção fúngica da pele, método para tratar uma infecção da pele por dermatófito, método para tratar infecção da pele e processo para a fabricação de uma composição farmacêutica tópica
|
DE102005048898A1
(de)
|
2005-10-12 |
2007-04-19 |
Sanofi-Aventis Deutschland Gmbh |
EGLN2-Varianten und ihre Verwendung bei der Vorbeugung oder Behandlung thromboembolischer Erkrankungen und koronarer Herzerkrankungen
|
EP1795609A1
(fr)
|
2005-12-06 |
2007-06-13 |
Sanofi-Aventis Deutschland GmbH |
Méthode de diagnostique et de traitement des maladies cardiovasculaires
|
WO2008007224A2
(fr)
|
2006-03-31 |
2008-01-17 |
Stiefel Research Australia Pty Ltd |
Gel de suspension moussant
|
US20070280972A1
(en)
*
|
2006-04-25 |
2007-12-06 |
Zars, Inc. |
Adhesive solid gel-forming formulations for dermal drug delivery
|
EP2626063B1
(fr)
|
2006-10-17 |
2022-03-16 |
Nuvo Pharmaceuticals Inc. |
Gel de diclofénac
|
DE102006049929B4
(de)
*
|
2006-10-19 |
2012-03-08 |
Beiersdorf Ag |
Filmbildende Gelkomposition zur Wund- bzw. Hautpflege
|
US20080260655A1
(en)
|
2006-11-14 |
2008-10-23 |
Dov Tamarkin |
Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
|
WO2008070602A2
(fr)
*
|
2006-12-04 |
2008-06-12 |
Smithkline Beecham Corporation |
Composition pharmaceutique topique
|
KR101301116B1
(ko)
|
2007-01-11 |
2013-09-03 |
애크럭스 디디에스 피티와이 리미티드 |
분산 기구
|
US8636982B2
(en)
|
2007-08-07 |
2014-01-28 |
Foamix Ltd. |
Wax foamable vehicle and pharmaceutical compositions thereof
|
EP2200550B1
(fr)
|
2007-10-18 |
2018-04-18 |
Rose U, LLC |
Formulations topiques de glycopyrrolate
|
WO2009069006A2
(fr)
|
2007-11-30 |
2009-06-04 |
Foamix Ltd. |
Peroxyde de benzoyle contenant de la mousse
|
WO2009072007A2
(fr)
|
2007-12-07 |
2009-06-11 |
Foamix Ltd. |
Porteurs, formulations, procédés pour formuler des agents actifs instables pour application externe et utilisations associées
|
EP2105742A1
(fr)
|
2008-03-26 |
2009-09-30 |
Sanofi-Aventis |
Utilisation de cathepsine C
|
CA2766282C
(fr)
|
2008-06-27 |
2021-03-02 |
Meta-Iq Aps |
Inhibiteurs de la carnitine palmitoyltransferase-1 pour le traitement et la prevention de troubles provoques par une delipidation du tissu nerveux
|
US20110165097A1
(en)
*
|
2008-09-10 |
2011-07-07 |
Novartis Ag |
Compositions for percutaneous administration
|
US9012477B2
(en)
*
|
2009-01-06 |
2015-04-21 |
Nuvo Research Inc. |
Method of treating neuropathic pain
|
US8618164B2
(en)
|
2009-03-31 |
2013-12-31 |
Nuvo Research Inc. |
Treatment of pain with topical diclofenac compounds
|
CA2760186C
(fr)
|
2009-04-28 |
2019-10-29 |
Foamix Ltd. |
Vehicule moussant et compositions pharmaceutiques comportant des solvants polaires aprotiques et leurs utilisations
|
CA2769677A1
(fr)
|
2009-07-29 |
2011-02-03 |
Foamix Ltd. |
Compositions hydro-alcooliques moussantes a base d'agents non tensioactifs non polymeres, mousses legeres, et leurs utilisations
|
CA2769625C
(fr)
|
2009-07-29 |
2017-04-11 |
Foamix Ltd. |
Compositions hydro-alcooliques moussantes non tensioactives, mousses legeres, et leurs utilisations
|
EP2293072A1
(fr)
|
2009-08-31 |
2011-03-09 |
Sanofi-Aventis |
Utilisation de la cathepsine H
|
US8871184B2
(en)
|
2009-10-02 |
2014-10-28 |
Foamix Ltd. |
Topical tetracycline compositions
|
US9849142B2
(en)
|
2009-10-02 |
2017-12-26 |
Foamix Pharmaceuticals Ltd. |
Methods for accelerated return of skin integrity and for the treatment of impetigo
|
WO2011088333A2
(fr)
|
2010-01-14 |
2011-07-21 |
Zars Pharma, Inc. |
Formulations pour anesthésie locale se solidifiant pour la gestion de la douleur
|
EP2444067A1
(fr)
|
2010-10-20 |
2012-04-25 |
Laboratorios Ojer Pharma S.L. |
Gel anhydrique comprenant muciprocin
|
US8481591B2
(en)
|
2010-11-01 |
2013-07-09 |
Stiefel Research Australia Pty. Ltd. |
Polymeric topical compositions
|
TW201241179A
(en)
|
2010-12-17 |
2012-10-16 |
Sanofi Sa |
MiRNAs in joint disease
|
TW201238974A
(en)
|
2010-12-17 |
2012-10-01 |
Sanofi Sa |
MiRNAs in joint disease
|
TW201239097A
(en)
|
2010-12-17 |
2012-10-01 |
Sanofi Sa |
MiRNAs in joint disease
|
TW201238973A
(en)
|
2010-12-17 |
2012-10-01 |
Sanofi Sa |
MiRNAs in joint disease
|
WO2012125214A1
(fr)
|
2011-03-17 |
2012-09-20 |
Transdermal Biotechnology, Inc. |
Systèmes topiques d'oxyde nitrique et leurs procédés d'utilisation
|
WO2012160125A1
(fr)
|
2011-05-26 |
2012-11-29 |
Novartis Ag |
Compositions destinées à l'administration percutanée d'agents physiologiquement actifs
|
US8871255B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Treatment of skin and soft tissue infection with nitric oxide
|
US8871261B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Cancer treatments and compositions for use thereof
|
US8871262B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Compositions and methods for treatment of osteoporosis and other indications
|
US8871257B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
|
US8871258B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Treatment and prevention of learning and memory disorders
|
US8871256B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and systems for treatment of inflammatory diseases with nitric oxide
|
US8871254B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
|
US8871260B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Methods and compositions for muscular and neuromuscular diseases
|
US8871259B2
(en)
|
2012-09-19 |
2014-10-28 |
Transdermal Biotechnology, Inc. |
Techniques and systems for treatment of neuropathic pain and other indications
|
KR101457789B1
(ko)
|
2013-02-13 |
2014-11-03 |
동아제약 주식회사 |
상처 치료용 필름형성 약제학적 조성물 및 그의 제조방법
|
US9241899B2
(en)
|
2013-03-13 |
2016-01-26 |
Transdermal Biotechnology, Inc. |
Topical systems and methods for treating sexual dysfunction
|
US9295636B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
US9295647B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
US9393265B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Wound healing using topical systems and methods
|
US9295637B2
(en)
|
2013-03-13 |
2016-03-29 |
Transdermal Biotechnology, Inc. |
Compositions and methods for affecting mood states
|
US9314422B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
US20140271731A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
US9687520B2
(en)
|
2013-03-13 |
2017-06-27 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
US20140271937A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
US9849160B2
(en)
|
2013-03-13 |
2017-12-26 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
US9314433B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Methods and systems for treating or preventing cancer
|
US9387159B2
(en)
|
2013-03-13 |
2016-07-12 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
US9724419B2
(en)
|
2013-03-13 |
2017-08-08 |
Transdermal Biotechnology, Inc. |
Peptide systems and methods for metabolic conditions
|
US9320706B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
US9314417B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Treatment of skin, including aging skin, to improve appearance
|
US9339457B2
(en)
|
2013-03-13 |
2016-05-17 |
Transdermal Biotechnology, Inc. |
Cardiovascular disease treatment and prevention
|
US9750787B2
(en)
|
2013-03-13 |
2017-09-05 |
Transdermal Biotechnology, Inc. |
Memory or learning improvement using peptide and other compositions
|
US9314423B2
(en)
|
2013-03-13 |
2016-04-19 |
Transdermal Biotechnology, Inc. |
Hair treatment systems and methods using peptides and other compositions
|
US9393264B2
(en)
|
2013-03-13 |
2016-07-19 |
Transdermal Biotechnology, Inc. |
Immune modulation using peptides and other compositions
|
US9320758B2
(en)
|
2013-03-13 |
2016-04-26 |
Transdermal Biotechnology, Inc. |
Brain and neural treatments comprising peptides and other compositions
|
US20140271938A1
(en)
|
2013-03-13 |
2014-09-18 |
Transdermal Biotechnology, Inc. |
Systems and methods for delivery of peptides
|
USD750788S1
(en)
|
2013-11-26 |
2016-03-01 |
Acrux Dds Pty Ltd |
Topical spreading applicator
|
USD749225S1
(en)
|
2013-11-26 |
2016-02-09 |
Acrux Dds Pty Ltd |
Topical spreading applicator
|
TW201629140A
(zh)
|
2015-02-09 |
2016-08-16 |
Genepharm Biotech Corp |
可成膜的凝膠組成物
|
KR101580077B1
(ko)
*
|
2015-03-28 |
2015-12-24 |
한국콜마주식회사 |
시크로피록스 함유 네일락카 조성물
|
CA2978573A1
(fr)
|
2016-09-08 |
2018-03-08 |
Foamix Pharmaceuticals Ltd. |
Compositions et methodes de traitement de la rosacee et de l'acnee
|